AI提升医疗效率，但数据隐私风险亟需合规与透明机制
Implications of Artificial Intelligence on Health Data Privacy and Confidentiality
- 以HIPAA为框架，构建AI医疗中的数据保护机制
- 案例显示AI在糖尿病视网膜病变等场景中存在数据共享争议
- 适合关注医疗AI伦理与合规的从业者及政策制定者
人工智能（AI）在医疗领域的快速融合正推动医学诊断、个性化治疗和运营效率的变革。然而，随之而来的患者数据隐私、伦理问题与监管合规挑战不容忽视。本文分析了AI对医疗的双重影响，强调其变革潜力与保护敏感健康信息的紧迫性。通过研究糖尿病视网膜病变、肿瘤学等应用案例，以及数据共享引发的争议，揭示了AI实施中的法律与伦理复杂性。研究表明，应在促进创新的同时维护患者信任与隐私，关键在于持续教育、透明化操作与严格遵守如《健康保险可携性和责任法案》（HIPAA）等监管框架，以实现负责任且合乎伦理的医疗AI发展。
原文摘要 · Abstract (English)
The rapid integration of artificial intelligence (AI) in healthcare is revolutionizing medical diagnostics, personalized medicine, and operational efficiency. However, alongside these advancements, significant challenges arise concerning patient data privacy, ethical considerations, and regulatory compliance. This paper examines the dual impact of AI on healthcare, highlighting its transformative potential and the critical need for safeguarding sensitive health information. It explores the role of the Health Insurance Portability and Accountability Act (HIPAA) as a regulatory framework for ensuring data privacy and security, emphasizing the importance of robust safeguards and ethical standards in AI-driven healthcare. Through case studies, including AI applications in diabetic retinopathy, oncology, and the controversies surrounding data sharing, this study underscores the ethical and legal complexities of AI implementation. A balanced approach that fosters innovation while maintaining patient trust and privacy is imperative. The findings emphasize the importance of continuous education, transparency, and adherence to regulatory frameworks to harness AI's full potential responsibly and ethically in healthcare.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品；中文卡片由大模型生成，请以原文为准。